(TER) Teradyne - Overview
Stock: Semiconductor Testers, Collaborative Robots, Mobile Robots, Wireless Testers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.43% |
| Yield on Cost 5y | 0.48% |
| Yield CAGR 5y | 4.66% |
| Payout Consistency | 98.1% |
| Payout Ratio | 12.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 56.6% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.82 |
| Alpha | 142.02 |
| Character TTM | |
|---|---|
| Beta | 1.866 |
| Beta Downside | 2.069 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.18% |
| CAGR/Max DD | 0.73 |
Description: TER Teradyne December 17, 2025
Teradyne (NASDAQ: TER) designs, builds, and sells automated test equipment and robotics solutions worldwide, operating through three segments: Semiconductor Test, Robotics, and Other.
The Semiconductor Test segment supplies wafer-level, package, and system-level testing platforms-including the FLEX, J750, Magnum, and ETS systems-to integrated device manufacturers, fabless designers, foundries, and test subcontractors, covering high-growth end-markets such as automotive electronics, AI-enabled chips, and 5G smartphones.
The Robotics segment offers collaborative arms, autonomous mobile robots, and advanced control software for manufacturing and logistics, while also marketing test and inspection instruments under the LitePoint brand for wireless and semiconductor validation.
Key recent metrics: FY 2023 revenue reached $3.5 billion, with the Semiconductor Test business contributing roughly 70 % of sales; operating margin held at ≈ 15 %; and the Robotics segment grew ≈ 12 % YoY, driven by rising demand for flexible automation in e-commerce fulfillment centers.
Sector drivers that materially affect Teradyne include the global semiconductor capital-expenditure cycle (average 6-7 % YoY growth in 2024), accelerating automotive electrification (projected 20 % CAGR in power-train chips), and tightening labor markets that push manufacturers toward automation.
For a deeper quantitative dive, you might explore ValueRay’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 554.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -1.98 > 1.0 |
| NWC/Revenue: 26.15% < 20% (prev 42.26%; Δ -16.12% < -1%) |
| CFO/TA 0.16 > 3% & CFO 674.4m > Net Income 554.0m |
| Net Debt (53.4m) to EBITDA (779.7m): 0.07 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.7m) vs 12m ago -3.39% < -2% |
| Gross Margin: 58.32% > 18% (prev 0.58%; Δ 5774 % > 0.5%) |
| Asset Turnover: 80.98% > 50% (prev 76.03%; Δ 4.94% > 0%) |
| Interest Coverage Ratio: 81.33 > 6 (EBITDA TTM 779.7m / Interest Expense TTM 8.02m) |
Altman Z'' 5.10
| A: 0.20 (Total Current Assets 1.94b - Total Current Liabilities 1.10b) / Total Assets 4.17b |
| B: 0.16 (Retained Earnings 686.8m / Total Assets 4.17b) |
| C: 0.17 (EBIT TTM 652.5m / Avg Total Assets 3.94b) |
| D: 2.03 (Book Value of Equity 2.80b / Total Liabilities 1.37b) |
| Altman-Z'' Score: 5.10 = AAA |
Beneish M -2.55
| DSRI: 1.45 (Receivables 773.6m/471.4m, Revenue 3.19b/2.82b) |
| GMI: 1.00 (GM 58.32% / 58.48%) |
| AQI: 1.07 (AQ_t 0.38 / AQ_t-1 0.35) |
| SGI: 1.13 (Revenue 3.19b / 2.82b) |
| TATA: -0.03 (NI 554.0m - CFO 674.4m) / TA 4.17b) |
| Beneish M-Score: -2.55 (Cap -4..+1) = A |
What is the price of TER shares?
Over the past week, the price has changed by +24.50%, over one month by +31.14%, over three months by +62.33% and over the past year by +164.24%.
Is TER a buy, sell or hold?
- StrongBuy: 9
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the TER price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 301.7 | 0.5% |
| Analysts Target Price | 301.7 | 0.5% |
| ValueRay Target Price | 328.8 | 9.6% |
TER Fundamental Data Overview February 07, 2026
P/E Forward = 51.0204
P/S = 13.5202
P/B = 15.0724
P/EG = 2.2714
Revenue TTM = 3.19b USD
EBIT TTM = 652.5m USD
EBITDA TTM = 779.7m USD
Long Term Debt = 127.8m USD (estimated: total debt 347.1m - short term 219.3m)
Short Term Debt = 219.3m USD (from shortTermDebt, last quarter)
Debt = 347.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 53.4m USD (from netDebt column, last quarter)
Enterprise Value = 43.15b USD (43.13b + Debt 347.1m - CCE 322.0m)
Interest Coverage Ratio = 81.33 (Ebit TTM 652.5m / Interest Expense TTM 8.02m)
EV/FCF = 95.81x (Enterprise Value 43.15b / FCF TTM 450.4m)
FCF Yield = 1.04% (FCF TTM 450.4m / Enterprise Value 43.15b)
FCF Margin = 14.12% (FCF TTM 450.4m / Revenue TTM 3.19b)
Net Margin = 17.37% (Net Income TTM 554.0m / Revenue TTM 3.19b)
Gross Margin = 58.32% ((Revenue TTM 3.19b - Cost of Revenue TTM 1.33b) / Revenue TTM)
Gross Margin QoQ = 57.49% (prev 58.41%)
Tobins Q-Ratio = 10.35 (Enterprise Value 43.15b / Total Assets 4.17b)
Interest Expense / Debt = 1.04% (Interest Expense 3.62m / Debt 347.1m)
Taxrate = 10.18% (29.2m / 286.4m)
NOPAT = 586.0m (EBIT 652.5m * (1 - 10.18%))
Current Ratio = 1.76 (Total Current Assets 1.94b / Total Current Liabilities 1.10b)
Debt / Equity = 0.12 (Debt 347.1m / totalStockholderEquity, last quarter 2.80b)
Debt / EBITDA = 0.07 (Net Debt 53.4m / EBITDA 779.7m)
Debt / FCF = 0.12 (Net Debt 53.4m / FCF TTM 450.4m)
Total Stockholder Equity = 2.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.06% (Net Income 554.0m / Total Assets 4.17b)
RoE = 19.88% (Net Income TTM 554.0m / Total Stockholder Equity 2.79b)
RoCE = 22.38% (EBIT 652.5m / Capital Employed (Equity 2.79b + L.T.Debt 127.8m))
RoIC = 21.05% (NOPAT 586.0m / Invested Capital 2.78b)
WACC = 12.70% (E(43.13b)/V(43.48b) * Re(12.79%) + D(347.1m)/V(43.48b) * Rd(1.04%) * (1-Tc(0.10)))
Discount Rate = 12.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.38%
[DCF Debug] Terminal Value 63.26% ; FCFF base≈459.9m ; Y1≈468.6m ; Y5≈515.2m
Fair Price DCF = 29.71 (EV 4.71b - Net Debt 53.4m = Equity 4.65b / Shares 156.6m; r=12.70% [WACC]; 5y FCF grow 1.70% → 2.90% )
EPS Correlation: -5.22 | EPS CAGR: 17.60% | SUE: 4.0 | # QB: 2
Revenue Correlation: 13.53 | Revenue CAGR: 10.09% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-03-31): EPS=2.11 | Chg30d=+0.899 | Revisions Net=+5 | Analysts=15
EPS current Year (2026-12-31): EPS=6.24 | Chg30d=+1.104 | Revisions Net=+6 | Growth EPS=+57.5% | Growth Revenue=+31.0%
EPS next Year (2027-12-31): EPS=8.01 | Chg30d=+1.490 | Revisions Net=+6 | Growth EPS=+28.4% | Growth Revenue=+18.8%